Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries

• Published in: Catheterization and cardiovascular interventions Vol. 69; no. 6; pp. 821 - 825
• Main Authors: Lee, Cheol Whan, Suh, Jon, Lee, Se-Whan, Park, Duk-Woo, Lee, Seung-Hwan, Kim, Young-Hak, Hong, Myeong-Ki, Kim, Jae-Joong, Park, Seong-Wook, Park, Seung-Jung
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.05.2007
• Subjects: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary - adverse effects; Cardiovascular Agents - administration & dosage; Cardiovascular Agents - adverse effects; Coronary Angiography; Coronary Disease - diagnosis; Coronary Disease - etiology; Coronary Disease - mortality; Coronary Restenosis - diagnosis; Coronary Restenosis - etiology; Coronary Stenosis - drug therapy; Coronary Stenosis - mortality; Coronary Stenosis - pathology; Coronary Stenosis - therapy; Coronary Vessels - pathology; Female; Follow-Up Studies; Humans; Male; Middle Aged; Odds Ratio; Predictive Value of Tests; predictors; Prospective Studies; restenosis; Risk Assessment; Risk Factors; Sirolimus - administration & dosage; Sirolimus - adverse effects; sirolimus-eluting stents; Stents - adverse effects; Time Factors; Treatment Outcome
• ISSN: 1522-1946; 1522-726X
• DOI: 10.1002/ccd.21019

Objectives: Predictors of cardiac events and restenosis after sirolimus‐eluting stent (SES) implantation in small coronary arteries were evaluated. Background: Although SES implantation has markedly reduced the risk of restenosis, small vessel disease remains a major cause of SES failure. Methods: We prospectively investigated the factors predictive of cardiac events and restenosis in 1,092 consecutive patients who received SES implantation for 1,269 lesions in small coronary arteries (≤2.8 mm). Follow‐up angiography at 6 months was performed in 751 patients with 889 lesions (follow‐up rate 70.3%). Results: Restenosis (diameter stenosis ≥ 50%) was angiographically documented in 65 patients with 77 lesions (8.7%): 55 focal (71.4%), 8 diffuse (10.4%), 2 diffuse proliferative (2.6%), and 12 total (15.6%). Lesion length, stent length, reference artery size, and in‐stent restenotic lesions were univariate predictors of restenosis. By multivariate analysis, lesion length (OR 1.04; 95% CI 1.02–1.05; P < 0.001) and in‐stent restenotic lesions (OR 3.38; 95% CI 1.80–6.35; P < 0.001) were significant independent predictors of restenosis. During follow‐up (23.2 ± 7.9 months), there were 17 deaths (5 cardiac and 12 noncardiac), 5 nonfatal Q‐wave myocardial infarctions, and 42 target lesion revascularizations. The cumulative probability of survival without major adverse cardiac events (MACE) was (96.6 ± 0.6)% at 1 year and (95.1 ± 0.7)% at 2 years. In multivariate analysis, lesion length (HR 1.04; 95% CI 1.01–1.07; P = 0.004) and in‐stent restenotic lesions (HR 3.29; 95% CI 1.58–6.86; P = 0.001) were independently related to MACE. Conclusions: SES implantation in small coronary arteries is safe and effective, with lesion length having a major impact on restenosis and MACE. © 2006 Wiley‐Liss, Inc.